Join us at Xconomy's EXOME Presents: What's Hot in Boston Biotech
5.11.2017 AGENDA
12:30 – 1:30Registration & Networking
1:30 – 1:40Welcome & Opening Remarks
Bob Buderi, Founder & CEO, Xconomy
Paul McKenzie, EVP for Pharmaceutical Operations and Technology, Biogen
1:40 – 2:10Standing Up for Immigration and Diversity in Biotech
Tony Coles, Chairman & CEO, Yumanity Therapeutics
Susan Windham-Bannister, President and CEO, Biomedical Growth Strategies; Managing Partner, Biomedical Innovation Advisors
Jeremy Levin, CEO, Ovid Therapeutics; former CEO, Teva Pharmaceutical Industries
Teresa Lavoie, Partner, Fish & Richardson (moderator)
2:10 – 2:35The Life Sciences in 2017 and Beyond: An Interactive Chat
Stelios Papadopoulos, Chairman of the Board, Biogen; Co-founder & Chairman of the Board, Exelixis
Bob Buderi, Founder & CEO, Xconomy
2:35 – 3:05Battling the Opioid Crisis
Richard Pops, Chairman & CEO, Alkermes
Peter Koutoujian, Sheriff of Middlesex County, former member, Massachusetts House of Representatives
3:05 – 3:35Patient-Centric Drug Development
Ed Kaye, President & CEO, Sarepta Therapeutics
Peter Saltonstall, President & CEO, National Organization for Rare Disorders
Abbie Celniker, Partner, Third Rock Ventures (moderator)
3:35 – 4:05Break
4:05 – 4:25Pioneering Life Science Ventures
Noubar Afeyan, Founder, Senior Managing Partner & CEO, Flagship Pioneering
4:25 – 5:00Translating Science and Company Building: A Chat With Two Serial Entrepreneurs
Michael Gilman, CEO & Chairman, Arrakis Therapeutics
Katrine Bosley, CEO, Editas Medicine
5:00 – 5:30Cancer Therapies of the Future
Laurie Glimcher, President & CEO, Dana-Farber Cancer Institute
David Schenkein, CEO, Agios Pharmaceuticals
5:30 – 6:30Networking Reception

*Schedule is subject to change.

Join us on May 11, register now.